期刊文献+

卵巢癌的诊断中多项肿瘤标志物联检的临床评价 被引量:2

下载PDF
导出
出处 《放射免疫学杂志》 CAS 2008年第5期416-417,共2页 Journal of Radioimmanology
  • 引文网络
  • 相关文献

参考文献3

二级参考文献5

共引文献67

同被引文献29

  • 1张久聪,董茜,邵彬.胸腺肽α1的作用机制和临床应用[J].细胞与分子免疫学杂志,2006,22(4):547-549. 被引量:55
  • 2秦万平,林勍.血清CA125、CA199、CA153联合检测在卵巢肿瘤中的运用[J].江西医学院学报,2006,46(5):79-80. 被引量:13
  • 3乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:5.
  • 4连丽娟.林巧稚妇科肿瘤学[M].3版.北京:人民卫生出版社,2006:461.
  • 5Moore RG,MacLaughlan S,Bast RC Jr.Current state of biomarkerdevelopment for clinical application in epithelial ovarian cancer[J].Gynecol Oncol,2010,116(2):240-245.
  • 6Schclartz PE,Taylor KJ.Is early detection of ovarian cancer possi-ble[J].Ann Med,1995,27(5):519-528.
  • 7Kirchhoff C,Habben I,Ivell R,et al.A major human epididymis-specific cDNA encodes a protein with sequence homology to extra-cellular proteinase inhibitors[J].Biol Reprod,1991,45(2):350-357.
  • 8Galqano MT,Hampton GM,Frierson HF Jr.Comprehensive analy-sis of HE4 expression in normal and malignant human tissues[J].Modern Pathology,2006,19(6):847-853.
  • 9Lu KH,Patterson AP,Wang L,et al.Selection of potential markersfor epithelial ovarian cancer with gene expression arrays and recur-sive descent partition analysis[J].Clin Cancer Res,2004,10(10):3291-3300.
  • 10Shah CA,Lowe KA,Paley P,et al.Influence of ovarian cancer riskstatus on the diagnostic performance of the serum biomarkers me-sothelin,HE4,and CA125[J].Cancer Epidemiol BiomarkersPrev,2009,18(5):1365-1372.

引证文献2

二级引证文献14

;
使用帮助 返回顶部